Endobronchial Ultrasonography for Positron Emission Tomography and Computed Tomography–Negative Lymph Node Staging in Non-Small Cell Lung Cancer Masato Shingyoji, MD, PhD, Takahiro Nakajima, MD, PhD, Mitsuru Yoshino, MD, PhD, Yasushi Yoshida, MD, PhD, Hironori Ashinuma, MD, PhD, Meiji Itakura, MD, PhD, Koichiro Tatsumi, MD, PhD, Toshihiko Iizasa, MD, PhD The Annals of Thoracic Surgery Volume 98, Issue 5, Pages 1762-1767 (November 2014) DOI: 10.1016/j.athoracsur.2014.05.078 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Flow diagram of patients who were diagnosed with cT1b-3N0M0 non-small cell lung cancer by both positron emission tomography (PET)–computed tomography (CT) and CT and who underwent endobronchial ultrasonography (EBUS). (BSC = best supportive care; EGFR-TKI = epidermal growth factor receptor–tyrosine kinase inhibitor.) The Annals of Thoracic Surgery 2014 98, 1762-1767DOI: (10.1016/j.athoracsur.2014.05.078) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions